Hemostemix OTC Stock Top Insiders
| HMTXF Stock | USD 0.06 0.0004 0.64% |
Hemostemix employs about 6 people. The company is managed by 6 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Hemostemix's management performance can provide insight into the company performance.
| BA BA Insider President, CoFounder |
| MD Sr Insider Chief Officer |
Hemostemix |
Hemostemix Management Team Effectiveness
The company has return on total asset (ROA) of (2.4947) % which means that it has lost $2.4947 on every $100 spent on assets. This is way below average. Hemostemix's management efficiency ratios could be used to measure how well Hemostemix manages its routine affairs as well as how well it operates its assets and liabilities.Hemostemix Workforce Comparison
Hemostemix is rated # 3 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 143. Hemostemix holds roughly 6.0 in number of employees claiming about 4% of equities under Health Care industry.
Hemostemix Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Hemostemix Price Series Summation is a cross summation of Hemostemix price series and its benchmark/peer.
Hemostemix Notable Stakeholders
A Hemostemix stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hemostemix often face trade-offs trying to please all of them. Hemostemix's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hemostemix's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| BA BA | President, CoFounder | Profile | |
| MD Sr | Chief Officer | Profile | |
| Thomas CA | Pres Inc | Profile | |
| Peter Pavlin | VP Operations | Profile | |
| Cameron Cole | Head Relations | Profile | |
| Christina CPA | Interim Officer | Profile |
About Hemostemix Management Performance
The success or failure of an entity such as Hemostemix often depends on how effective the management is. Hemostemix management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hemostemix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hemostemix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Hemostemix Inc., a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company is also developing various types of cell products, such as synergetic cell populations and neural cell precursors. Hemostemix is traded on OTC Exchange in the United States.
The data published in Hemostemix's official financial statements typically reflect Hemostemix's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Hemostemix's quantitative information. For example, before you start analyzing numbers published by Hemostemix accountants, it's essential to understand Hemostemix's liquidity, profitability, and earnings quality within the context of the Biotechnology space in which it operates.
Hemostemix Workforce Analysis
Traditionally, organizations such as Hemostemix use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hemostemix within its industry.Hemostemix Manpower Efficiency
Return on Hemostemix Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1M | |
| Net Loss Per Executive | 1M |
Complementary Tools for Hemostemix OTC Stock analysis
When running Hemostemix's price analysis, check to measure Hemostemix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemostemix is operating at the current time. Most of Hemostemix's value examination focuses on studying past and present price action to predict the probability of Hemostemix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemostemix's price. Additionally, you may evaluate how the addition of Hemostemix to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |